Anti-influenza A virus restriction factors that shape the human species barrier and virus evolution
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
PLOS pathogens. - 19, 7 (2023) , e1011450, ISSN: 1553-7374
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2023
- Urheber
- DOI
-
10.1371/journal.ppat.1011450
- URN
-
urn:nbn:de:bsz:25-freidok-2379067
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Petric, Philipp P.
- Schwemmle, Martin
- Graf, Laura Brigitte
- Universität
Entstanden
- 2023
Ähnliche Objekte (12)
Development of a chimeric bat influenza A virus as a live vaccine
Bats reveal the true power of influenza A virus adaptability
Bat influenza viruses: insights in the molecular biology and characterization of infectious viruses
Adaptation von Influenza-A-Viren an den humanen Restriktionsfaktor MxA
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets
The influenza A virus genome packaging network - complex, flexible and yet unsolved
Unexpected functional divergence of bat influenza virus NS1 proteins
Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11
An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus
Poly-ADP ribosyl polymerase 1 (PARP1) regulates influenza A virus polymerase
Internal viral RNA sequences of the PB2 genome segment of influenza A virus are required for efficient generation of fully infectious particles
A modified live bat influenza A virus-based vaccine prototype provides full protection against HPAIV H5N1
Development of a chimeric bat influenza A virus as a live vaccine
Bats reveal the true power of influenza A virus adaptability
Bat influenza viruses: insights in the molecular biology and characterization of infectious viruses
Adaptation von Influenza-A-Viren an den humanen Restriktionsfaktor MxA
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets
The influenza A virus genome packaging network - complex, flexible and yet unsolved
Unexpected functional divergence of bat influenza virus NS1 proteins
Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11
An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus
Poly-ADP ribosyl polymerase 1 (PARP1) regulates influenza A virus polymerase
Internal viral RNA sequences of the PB2 genome segment of influenza A virus are required for efficient generation of fully infectious particles
A modified live bat influenza A virus-based vaccine prototype provides full protection against HPAIV H5N1
Development of a chimeric bat influenza A virus as a live vaccine
Bats reveal the true power of influenza A virus adaptability
Bat influenza viruses: insights in the molecular biology and characterization of infectious viruses
Adaptation von Influenza-A-Viren an den humanen Restriktionsfaktor MxA
Bat-borne H9N2 influenza virus evades MxA restriction and exhibits efficient replication and transmission in ferrets
The influenza A virus genome packaging network - complex, flexible and yet unsolved
Unexpected functional divergence of bat influenza virus NS1 proteins
Human MxA is a potent interspecies barrier for the novel bat-derived influenza A-like virus H18N11
An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus
Poly-ADP ribosyl polymerase 1 (PARP1) regulates influenza A virus polymerase
Internal viral RNA sequences of the PB2 genome segment of influenza A virus are required for efficient generation of fully infectious particles